Core Outcome Measures in Effectiveness Trials

Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators

General Information

Abstract:
Not provided

Aim:
The third edition of Migraine Clinical Trials Guidelines is a consensus summary that was developed by experts in the field, and its purpose is to recommend a contemporary, standardized, and evidence-based approach to the conduct and reporting of migraine RCTs.

Authors:
Tfelt-Hansen, P. Pascual, J. Ramadan, N. Dahlof, C. D'Amico, D. Diener, H. C. Hansen, J. M. Lanteri-Minet, M. Loder, E. McCrory, D. Plancade, S. Schwedt, T. International Headache Society Clinical Trials, Subcommittee

Publication

Journal:
Cephalalgia
Volume:
32
Issue:
1
Pages:
6 - 38
Year:
2012
DOI:
Further Study Information

Date:
Not stated
Funding source(s):
Not stated

Health Area

Disease Category
Neurology

Disease Name
Migraine

Target Population

Age Range
18 - 65

Sex
Either


Nature / type of Intervention
Drug

Method(s)

Unknown

Stakeholders Involved

Clinical experts
Other (unknown)

Status of Core Outcome Set

Consensus
Recommended outcome measures (measurement)
Revised

The site uses cookies, some may have been set already. Please refer to our privacy policy & cookie usage statement.
If you continue to use the site we'll assume you're happy to accept the cookies.